Corbion NV ADR (CSNVY)

Featured in Small-Cap Stocks

Corbion N.V. ADR is a depositary receipt representing common stock of Corbion N.V., an Amsterdam-based company founded in 1903 and listed on OTC Markets. The underlying issuer develops lactic acid and derivative products, food preservation solutions, functional ingredient systems, and algae-based nutritional ingredients. Its operations are organized into two segments: Functional Ingredients & Solutions and Health & Nutrition. Corbion serves customers across the Netherlands, the United States, Asia, the rest of the Americas, Europe, the Middle East, and Africa. Its product portfolio includes fermentation and preservation ingredients, food safety and shelf-life solutions, feed and animal nutrition products, medical and pharmaceutical polymers, solvents, personal care ingredients, and algae ingredients.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-CSNV.Y
$28.87
26.6% Upside
Undervalued
Good
0.91
2.5%
October 28, 2026
15.3x
1.5x
0.9x
1.302 B
1.819 B
28.2%
89.3%
8.1
49.7%
123.9%
Valuation • Fair Value

Corbion NV ADR (OTC-CSNV.Y) Fair Value by Valuation Model

Compare the primary fair value estimate for Corbion NV ADR (OTC-CSNV.Y) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$28.87

Estimated upside of 26.6% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$32.17

Discounted cash flow valuation reference.

Ben Graham Formula Value

$16.44

Classic Ben Graham valuation formula reference.

DDM Fair Value

$27.77

Dividend discount model valuation reference.

EPV Fair Value

$12.75

Earnings power value estimate.

Comps Fair Value

$28.64

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Corbion NV ADR (OTC-CSNV.Y) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Corbion NV ADR (OTC-CSNV.Y)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.489 B

Current operating scale indicator.

Revenue Forecast

1.455 B

Forward revenue estimate.

EBITDA

220.3 M

Current operating profitability reference.

EBITDA Forecast

237.9 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Corbion NV ADR (OTC-CSNV.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Corbion NV ADR (OTC-CSNV.Y)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.93

No elevated caution signal from this screen.

Altman Z-Score

8.1

Relatively strong balance-sheet zone.

FCF / Net Income

123.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Corbion NV ADR (OTC-CSNV.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Corbion NV ADR (OTC-CSNV.Y)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

October 28, 2026

Days to Earnings

99

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.5%

Income yield reference.

Upcoming Dividend

0.91

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

49.7%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Corbion NV ADR (OTC-CSNV.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Corbion NV ADR (OTC-CSNV.Y) Stock Forecast & Technical Outlook

Review Corbion NV ADR (OTC-CSNV.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Corbion NV ADR (OTC-CSNV.Y) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Corbion NV ADR (OTC-CSNV.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Corbion NV ADR (OTC-CSNV.Y) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Corbion NV ADR (OTC-CSNV.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Corbion NV ADR (OTC-CSNV.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Corbion NV ADR (OTC-CSNV.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Corbion NV ADR (OTC-CSNV.Y) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

Corbion NV ADR (OTC-CSNV.Y) Stock FAQ

Quick answers about Corbion NV ADR (OTC-CSNV.Y) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$28.87
Estimated upside 26.6%
Valuation Rating
Undervalued
Estimated upside of 26.6%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Good
Current financial-health read

The current fair value estimate for Corbion NV ADR (OTC-CSNV.Y) is $28.87. This implies an estimated upside of 26.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 26.6% versus the current market price.

An analyst price target for Corbion NV ADR (OTC-CSNV.Y) is not currently available in the latest data file.

The current financial health read for Corbion NV ADR (OTC-CSNV.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Corbion NV ADR (OTC-CSNV.Y) is October 28, 2026.

Based on the current data, dividend yield is 2.5%, upcoming dividend amount is 0.91.

The current P/E ratio listed for Corbion NV ADR (OTC-CSNV.Y) is 15.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Corbion NV ADR is 1.302 B.

The current enterprise value listed for Corbion NV ADR is 1.819 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Corbion NV ADR is OTC-CSNV.Y, and the stock is listed on OTC Markets.

Corbion NV ADR (OTC-CSNV.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Corbion NV ADR is 28.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Corbion NV ADR is 89.3%. Free float helps investors understand how much of the share base is available for public trading.